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The effect of zinc gluconate in treatment of children aged 2-23 months with acute 
bronchiolitis admitted to the infectious ward of bo-ali hospital of ardabil city in 2018 
Abstract 
Background and objective: Acute viral bronchiolitis is the most common infection of the lower 
respiratory tract in infants under 2 years and is one of the reasons for their admission all around 
the world. The aim of this study was to investigate the effect of zinc gluconate in treatment of 
children aged 2-23 months with acute bronchiolitis admitted to the infectious ward of Bo-Ali 
hospital of Ardabil city in 2018. 
Methods: Thid study was a randomized clinical trial in which 100 infants aged 2- 32 months 
with the diagnosis of bronchiolitis were included in the study considering inclusion and 
exclusion criteria. 50 patients received zinc gluconate and 50 patients received placebo. The 
symptoms and sign of the disease at baseline and then at 24, 72, and 7 days after starting 
treatment and duration of hospitalization were compared between the two groups. 
Results: The treatment and placebo groups were similar in respect to mean age (5.82±4.13 vs 
5.94±4.46, respectively, and P=0.889) and gender distribution (31 male vs 28 male, respectively, 
and P=0.542). There was no significant difference between the two groups in terms of clinical 
symptoms and signs at the time of admission. Bronchiolitis recovery was better in the treatment 
group than in the placebo group; This positive effect was statistically significant for vising (P = 
0.023) and rhinorrhea (P = 0.027) 72 hours after starting treatment. Significantly, more patients 
in the treatment group were improved within 72 hours after starting treatment (74% vs 46% and 
P=0.004) and the mean duration of hospitalization was significantly less in the treatment group 
than in the placebo group (4.14±1.21 versus 4.64±1.2 days and P = 0.016). 
Conclusion: The findings of this study showed that the use of zinc gluconate as a zinc 
supplement in infants aged 2 to 23 months with acute bronchiolitis admitted to hospital could 
improve clinical symptoms and signs and decrease the duration of hospitalization. However, 
given the limited studies in this area, further research is needed to provide appropriate 
recommendations for zinc use in the treatment of bronchiolitis in other populations. 
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